Peter Roselt
-
- Radiopharmaceutical Chemistry and Applications 37
- Medical Imaging Techniques and Applications 18
- Monoclonal and Polyclonal Antibodies Research 5
- Oncology top 5%
- Peptidase Inhibition and Analysis 13
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 7
-
- Prostate Cancer Treatment and Research 7
- Pharmaceutical Science top 10%
-
- Chemical Synthesis and Analysis 8
-
- Neuroendocrine Tumor Research Advances 8
- Co-authors
- Rodney J. HicksCarleen CullinanePaul S. DonnellyDavid BinnsDonna S. DorowAndrew KatsifisJonathan M. WhiteOliver Neels
- Journals
- Journal of Nuclear Medicine (7 papers)Bioconjugate Chemistry (4 papers)Journal of Medicinal Chemistry (4 papers)
- Partner nations
- AustraliaUnited StatesFrance
In The Last Decade
Peter Roselt
69 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 89
- Radiology, Nuclear Medicine and Imaging 980
- Oncology 541
- Cancer Research 198
- Pulmonary and Respiratory Medicine 337
- Pharmaceutical Science 50
Countries citing papers authored by Peter Roselt
This map shows the geographic impact of Peter Roselt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Roselt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Roselt more than expected).
Fields of papers citing papers by Peter Roselt
This network shows the impact of papers produced by Peter Roselt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Roselt. The network helps show where Peter Roselt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Roselt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 15 | |
| 4 | 2022 | 22 | |
| 5 | AUTOMATED RADIOSYNTHESIS OF [(89)ZR]ZR-DFOSQ-DURVALUMAB ON THE IPHASE MULTISYN MODULE | 2021 | 3 |
| 6 | 2019 | 25 | |
| 7 | 2019 | 1 | |
| 8 | 2019 | 46 | |
| 9 | 2019 | 8 | |
| 10 | 2019 | 6 | |
| 11 | 2018 | 110 | |
| 12 | 2016 | 86 | |
| 13 | 2013 | 80 | |
| 14 | 2013 | 45 | |
| 15 | 2013 | 5 | |
| 16 | 2011 | 7 | |
| 17 | 2011 | 32 | |
| 18 | 2010 | 46 | |
| 19 | 2007 | 20 | |
| 20 | 2006 | 37 |
About Peter Roselt
Peter Roselt is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pharmaceutical Science, having authored 71 papers that have together received 1.7k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (37 papers), Medical Imaging Techniques and Applications (18 papers), Peptidase Inhibition and Analysis (13 papers), Chemical Synthesis and Analysis (8 papers), Neuroendocrine Tumor Research Advances (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), Prostate Cancer Treatment and Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (980 citations), Oncology (541 citations) and Cancer Research (198 citations). Peter Roselt has collaborated with scholars based in Australia, United States and France. Frequent co-authors include Rodney J. Hicks, Carleen Cullinane, Paul S. Donnelly, David Binns, Donna S. Dorow, Andrew Katsifis, Jonathan M. White, Oliver Neels, Delphine Denoyer and Charmaine M. Jeffery. Their work appears in journals such as Journal of Nuclear Medicine, Bioconjugate Chemistry, Journal of Medicinal Chemistry, European Journal of Nuclear Medicine and Molecular Imaging and Tetrahedron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.